Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders

Movement Disorders

Volumn 26, Issue 7, 2011, Pages 1218-1224

  King, Alisha E ^a   Mintz, Jim ^a   Royall, Donald R ^a,b,c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; Dementia with Lewy bodies; Multiple system atrophy; Parasomnias; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; POTASSIUM IODIDE; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ALZHEIMER DISEASE; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; HEART SCINTISCANNING; HUMAN; META ANALYSIS; MULTIINFARCT DEMENTIA; PARASOMNIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; METHODOLOGY; MYOCARDIAL PERFUSION IMAGING; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEWY BODY DISEASE; MYOCARDIAL PERFUSION IMAGING; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS;

EID: 79959366791     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23659     Document Type: Article

References (31)

1. Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, Lucking CH. Impaired cardiac uptake of meta-[123i]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand. 1998; 97: 307-314.
2. Courbon F, Brefel-Courbon C, Thalamas C, et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord. 2003; 18: 890-897.
3. Quinn N, Wenning G. Multiple system atrophy. Br J Hosp Med. 1994; 51: 492-494.
4. Fahn S, Elton R: Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Goldstein M, Calne D, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ, Macmillan Healthcare Information; 1987: 153-163.
5. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996; 47: 1-9.
6. Orimo S, Oka T, Miura H, et al. Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002; 73: 776-777.
7. Yoshida M. Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology. 2007; 27: 484-493.
8. Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F. Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. Adv Neurol. 1993; 60: 609-612.
9. Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol. 1997; 94: 192-196.
10. Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in parkinson's disease. Eur. Neurol. 1997; 38(Suppl 2): 2-7.
11. Orimo S, Amino T, Itoh Y, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 2005; 109: 583-588.
12. Orimo S, Uchihara T, Nakamura A, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain. 2008; 131: 642-650.
13. Orimo S, Kanazawa T, Nakamura A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol. 2007; 113: 81-86.
14. Imrich R, Eldadah BA, Bentho O, et al. Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension. Parkinsonism Relat Disord. 2009; 15: 122-127.
15. Walter BL. Cardiovascular autonomic dysfunction in patients with movement disorders. Cleve Clin J Med. 2008; 75(Suppl 2): S54-S58.
16. Aarsland D, Kurz M, Beyer M, Bronnick K, Piepenstock Nore S, Ballard C. Early discriminatory diagnosis of dementia with Lewy bodies. The emerging role of CSF and imaging biomarkers. Dement Geriatr Cogn Disord. 2008; 25: 195-205.
17. Williams MM, Xiong C, Morris JC, Galvin JE. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology. 2006; 67: 1935-1941.
18. McKeith IG, Dickson DW, Lowe J, et al, Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: Third Report of the DLB Consortium [see comment]. Neurology. 2005; 65: 1863-1872; Erratum, 2005;65:1992; summary for patients in neurology, 2005;65:E26-E27.
19. Akincioglu C, Unlu M, Tunc T. Cardiac innervation and clinical correlates in idiopathic Parkinson's disease. Nucl Med Commun. 2003; 24: 267-271.
20. Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N. Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease. J Neuro Sci. 2009; 276: 79-83.
21. Hanyu H, Shimizu S, Hirao K, et al. Comparative value of brain perfusion spect and [(123)i]mibg myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease [see comment]. Eur J Nucl Med Mol Imaging. 2006; 33: 248-253.
22. Raffel DM, Koeppe RA, Little R, et al. Pet measurement of cardiac and nigrostriatal denervation in parkinsonian syndromes. J Nucl Med. 2006; 47: 1769-1777.
23. Berding G, Schrader CH, Peschel T, et al. [n-Methyl 11c]meta-hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging. 2003; 30: 127-131.
24. Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO 3rd. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med. 2000; 133: 338-347.
25. Estorch M, Camacho V, Paredes P, et al. Cardiac (123)i-metaiodobenzylguanidine imaging allows early identification of dementia with lewy bodies during life. Eur J Nucl Med Mol Imaging. 2008; 35: 1636-1641.
26. Escamilla-Sevilla F, Perez-Navarro MJ, Munoz-Pasadas M, et al. [Diagnostic value of cardiac 123i-metaiodobenzylguanidine (123i-mibg) scintigraphy in Lewy body disorders]. Neurologia. 2009; 24: 170-176.
27. Kobayashi K, Sumiya H, Nakano H, Akiyama N, Urata K, Koshino Y. Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with meta-iodobenzylguanidine scintigraphy. Int J Geriatr Psychiatry. 2010; 25: 55-65.
28. Iranzo A, Santamaria J, Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev. 2009; 13: 385-401.
29. Kaufmann H, Goldstein DS. Pure autonomic failure: a restricted lewy body synucleinopathy or early parkinson disease? Neurology. 2010; 74: 536-537.
30. Okada Y, Ito Y, Aida J, Yasuhara M, Ohkawa S-I, Hirokawa K. Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies. Patholog Int. 2004; 54: 682-687.
31. Fujishiro H, Frigerio R, Burnett M, et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of parkinson's disease. Mov Disord. 2008; 23: 1085-1092.